Welcome to our exclusive webinar, where we invite you to explore the intersection of beauty and science with Neutrogena®, a leader in the skincare industry. Join us as we delve…
Read More
A New Outreach Program Demonstrates How Targeted Education Can Transform Access To Dermatologic Care Since its launch in 2020, DermmunityTM, a community service program run by the USC Department of…
Read More
A Concise Look at the IMMPulse Trial Comparing Apremilast And Risankizumab In Moderate Plaque Psoriasis In a compelling video interview for the Journal of Drugs in Dermatology, Dr. Christopher Bunick…
Read More
Several media outlets covered an August Journal of Drugs in Dermatology survey on the perceived dermatologic side effects of cancer treatments and how those perceptions could impact a person’s decision…
Read More
As the most common inflammatory skin disease, Acne Vulgaris is unavoidable in our line of work. By default, we have to be Princes/Princesses of Pimples, though fortunately we have a…
Read More
Oatmeal Uncovered: Your New Ally in Skin Health Discover why colloidal oatmeal has earned its spot in modern dermatology. At the JDD Oats in Skincare Educational Resource Center, we’ve assembled…
Read More
Transforming Routine Visits into Early‐Warning Systems for Psoriatic Arthritis What if every psoriasis appointment could double as a stealth screening for psoriatic arthritis? In one of our latest JDD articles titled…
Read More
Rice Bran Reimagined: A New Frontier in Hair Health Could this ancient grain extract be the next go-to for patients battling
Read More
Rethinking Spironolactone Dosing in Female Pattern Hair Loss Could a lower dose of spironolactone offer relief to women struggling with thinning hair? Female pattern hair loss (FPHL) is a multifactorial condition…
Read More
Elevate your practice with the very latest clinical insights, case studies, and CME, all in one place. Discover the Acne Resource Center - your new go-to microsite for the very…
Read More
Check out our all-new JDD Video Abstract from Christopher G. Bunick, who discusses PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact.
Read More
Boosting Psoriasis Outcomes with a Dual Strategy - Deucravacitinib Plus Calcipotriene/Betamethasone Foam Shows Lasting Benefits A promising new open-label study in our August issue highlights how adding topical calcipotriene/betamethasone dipropionate…
Read More
